Meetings & Events

2022 Pediatric Residents Program

 

2022 CARRA-Arthritis Foundation Pediatric Residents Program

Registration for the 2022 Pediatric Residents Program is now closed.

Orientation: March 22, 5-6:30 PM Eastern

Pediatric Residents Program Session: April 13, 7:30-9:00 PM Eastern

CARRA is a North American-based research organization of over 550 pediatric rheumatology investigators spanning more than 115 clinical practice sites. More than 95% of all board certified Pediatric Rheumatologists are members of CARRA. CARRA’s providers treat and study patients with all pediatric diseases such as JIA, lupus, dermatomyositis, localized scleroderma, systemic sclerosis, vasculitis, fibromyalgia, Kawasaki’s Disease, PFAPA, Sjögren’s Syndrome, CRMO, in addition to other auto-inflammatory diseases.

In the United States, 300,000 children are afflicted with arthritis and other rheumatic conditions, yet there are fewer than 350 pediatric rheumatologists across the country available to care for these children and half of children with rheumatic disease are seen by adult providers. To address the shortage of pediatric rheumatologists and to expose pediatric residents to the field of pediatric rheumatology, CARRA and the Arthritis Foundation are offering the Pediatric Residents Program.


CARRA Annual Scientific Meeting (ASM)

The CARRA Annual Meeting brings together physicians, scientific investigators, nurses, research coordinators, patients/caregivers, in addition to senior leadership from CARRA and the Arthritis Foundation. The meeting is primarily a working meeting, designed for groups to be able to meet in order to collaborate to prioritize and facilitate research projects. All attendees actively participate in various phases of research development in large committee meetings as well as many smaller topic-focused workgroups. Plenary sessions highlighting the latest and most important topics in research are also integral to the meeting program.

The goals of the CARRA-Arthritis Foundation Pediatric Residents Program are to:

  • Provide pediatric residents with access to the broad pediatric rheumatologic community through participation in CARRA’s Annual Scientific Meeting.
  • Encourage interested pediatric residents to consider pediatric rheumatology as a subspecialty, thus improve patient access to pediatric rheumatologists.
  • Introduce Pediatric Residents to the resources of the Arthritis Foundation.

To help achieve these goals, CARRA and the Arthritis Foundation are supporting pediatric residents’ attendance at CARRA’s 2022 Virtual Annual Scientific Meeting. All meetings and sessions will be held virtually with workgroup sessions in April leading up to CARRA’s 2-day Scientific Meeting May 2-3, 2022. Accepted applicants will have an orientation on March 22, 2022, from 5-6:30 PM Eastern to introduce them to CARRA, provide an overview of the 2022 ASM meetings, and review the meeting registration process.  All accepted applicants are expected to participate in the Pediatric Residents Program Session on April 13, 2022, from 7:30-9:00 PM Eastern and attend other 2022 ASM sessions of interest. 


Orientation Session for Pediatric Residents and Fellows

Tuesday, March 22, 2022, 5:00-6:30 PM ET

  • Welcome by CARRA Fellows Sub-Committee Co-chairs: Melissa Argraves and Christine Bacha
  • Introduction to CARRA and the Arthritis Foundation by the CARRA President, Emily von Scheven
  • Overview of the 2022 Virtual ASM and guide to meeting registration*

*Following the orientation session, all residents/meeting attendees will be provided with the link to register for the CARRA 2022 ASM, including all preconference and workgroup meetings, as well as the 2-day event on May 2-3, 2022.


CARRA's Mission

CARRA’s mission is to conduct collaborative research to prevent, treat and cure pediatric rheumatic diseases and its largest research project is called the CARRA Registry. The CARRA Registry is a long-term observational study being conducted at over 70 research sites in the US and Canada. The CARRA Registry is studying the long-term safety of medications used to treat pediatric rheumatic diseases and will follow at least 10,000 patients for 10 years.  CARRA also participates in clinical trials and has a growing internal grant program, funded in large part by the Arthritis Foundation.

CARRA's Vision

A world free of limitations from pediatric rheumatic diseases.


Questions

For any questions about the CARRA-Arthritis Foundation Pediatric Residents Program or application, please contact CARRA’s Assistant Executive Director, Jen Kowalski [email protected].


 

 

www.carragroup.org

www.arthritis.org